Clinical Trials List
Protocol NumberWTX101-301
Completed
2019-07-01 - 2023-04-25
Phase III
Terminated1
ICD-10E83.00
Disorder of copper metabolism, unspecified
ICD-10E83.01
Wilson's disease
ICD-10E83.09
Other disorders of copper metabolism
ICD-9275.1
Disorders of copper metabolism
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chi-Hung Liu Division of Neurology
- Hsiu-Chuan Wu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
180 participants
